Prevalence and phenotypic characterization of ESBL producing E.coli and Klebsiella among the fecal isolates of normal population

Introduction: Prevalence of extended spectrum beta lactamase producing bacteria has been increasing worldwide despite of outbreak situations. ESBLs occupying the gastrointestinal tract are spread across other bacteria and humans through the environment. The present study is a report on the prevalence of ESBL producers among normal individuals of a rural population in south India. Materials and Methods: 1000 normal individuals were selected from the villages of Salem district. Stool samples were collected and processed in MacConkey agar plates supplemented with Cefotaxime 5ug/ml. Morphological and biochemical methods were used to identify the colonies initially. ESBL producing organisms were identified by Double Disk Synergy Test – DDST and Phenotypic Confirmatory Disk Diffusion test- PCDDT. Results: From the total number of samples, 37.9% has shown bacterial growth. The rate of ESBL producing Enterobacteriaceae was found to be 33.8% with E.coli (29.3%) being the predominant species followed by klebsiella (8.6%). Conclusion: The results of our study gives a brief information about the multidrug resistance and also the prevalence of ESBL producing bacteria in the community faecal flora. Phenotypic methods were successfully applied to screen large number of samples. The rate of ESBL producers in the community is notably high. Routine surveillance programmes and awareness of hygienic practices among the rural population are highly recommended to monitor and control the spread. Keywords: Beta lactams, E.coli, Enterobacteriaceae, Klebsiella.

[1]  Y. Chander,et al.  Carriage of ESBL and AmpC-Positive Enterobacteriaceae in Gastrointestinal Tract of Healthy Community Subjects and Hospitalized Patients and Detection of blaCTX-M Gene in ESBL Positive Isolates. , 2015 .

[2]  Joseph M. Campos,et al.  Extended-spectrum Beta-lactamases: A Brief Clinical Update , 2011, The Pediatric infectious disease journal.

[3]  C. Rodrigues,et al.  Incidence of ESBL producers amongst Gram-negative bacilli isolated from intra-abdominal infections across India (based on SMART study, 2007 data). , 2011, The Journal of the Association of Physicians of India.

[4]  Zeina A Kanafani,et al.  Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. , 2011, Mayo Clinic proceedings.

[5]  P. Wayne CLINICAL AND LABORATORY STANDARDS INSTITUTE. PERFORMANCE STANDARDS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING , 2011 .

[6]  B. Veeraraghavan,et al.  Epidemiology and outcome of bacteremia caused by extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in a tertiary care teaching hospital in south India. , 2010, The Journal of the Association of Physicians of India.

[7]  P. Collignon,et al.  Colonisation with Escherichia coli resistant to “critically important” antibiotics: a high risk for international travellers , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[8]  O. Cars,et al.  Foreign Travel Is a Major Risk Factor for Colonization with Escherichia coli Producing CTX-M-Type Extended-Spectrum β-Lactamases: a Prospective Study with Swedish Volunteers , 2010, Antimicrobial Agents and Chemotherapy.

[9]  I. Odenholt,et al.  Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers’ diarrhoea , 2010, Scandinavian journal of infectious diseases.

[10]  F. Baquero,et al.  Antibiotic Coresistance in Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae and In Vitro Activity of Tigecycline , 2006, Antimicrobial Agents and Chemotherapy.

[11]  K. Angamuthu,et al.  Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia. , 2005, Saudi medical journal.

[12]  M. Kaufmann,et al.  Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. , 2004, The Journal of antimicrobial chemotherapy.

[13]  P. Nordmann,et al.  Emerging carbapenemases in Gram-negative aerobes. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  G. Jacoby,et al.  Plasmid-determined AmpC-type beta-lactamases. , 2002, Antimicrobial agents and chemotherapy.

[15]  B. Levin,et al.  Minimizing potential resistance: a population dynamics view. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  J. Pagés,et al.  Most Enterobacter aerogenes Strains in France Belong to a Prevalent Clone , 1999, Journal of Clinical Microbiology.

[17]  C. Quentin,et al.  Molecular epidemiology of a nosocomial outbreak due to SHV-4-producing strains of Citrobacter diversus , 1997, Journal of clinical microbiology.

[18]  A. Medeiros,et al.  Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  D. Livermore beta-Lactamases in laboratory and clinical resistance , 1995, Clinical microbiology reviews.

[20]  G. Jacoby,et al.  A functional classification scheme for beta-lactamases and its correlation with molecular structure , 1995, Antimicrobial agents and chemotherapy.

[21]  R. Ambler,et al.  The structure of beta-lactamases. , 1980, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[22]  H. B. Woodruff,et al.  Phosphonomycin, a New Antibiotic Produced by Strains of Streptomyces , 1969, Science.

[23]  Howard Florey,et al.  FURTHER OBSERVATIONS ON PENICILLIN , 1941 .